Company / Working Capital per Share
Foghorn Therapeutics Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.86
FY2025
5-year range
$1.86 / $7.17
FY2021-FY2025
Trend
-56.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $7.17 in FY2022 to $1.86 in FY2025.
Based on SEC 10-K filings.
1.86 in FY2025 with a 5-year CAGR of -44.5%.
Declined from $4.35 to $1.86 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -36.2%
- 5-Year CAGR
- -44.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Foghorn Therapeutics Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 56.9% year-over-year.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.86 | -56.9% |
| FY2024 | $4.32 | -0.7% |
| FY2023 | $4.35 | -39.4% |
| FY2022 | $7.17 | +53.5% |
| FY2021 | $4.67 | -86.8% |
| FY2020 | $35.28 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026